Cedars-Sinai Medical Center
Los Angeles, California, 90048, United States
NCT Number: NCT02163408
This is a technical development study with the goal to develop 3D techniques for atherosclerosis plaque characterization. We hypothesize that 3D MRI is superior to 2D MRI in characterizing major plaque constituents that contribute to severe clinical events such as myocardial infarction or stroke. The major advantages of the 3D techniques to be developed will include high spatial resolution, reduced scan times, and optimized image contrast. The use of contrast injection is not needed with the new techniques, which is greatly beneficial for patients with advanced chronic kidney disease.This is not a funded clinical trial.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Los Angeles, California, 90048, United States
All participants will undergo the conventional MRI protocol and the new imaging protocol using our developed techniques. They may have either non-contrast scans or contrast-enhanced scans or both depending on the stage of development. The comparison results between the two protocols will be used to evaluate the performance of the new techniques and help optimization of specific technical aspects.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Bilateral carotid plaque imaging at 3.0T. Conventional MRI scans with T1-, T2-weightings and scans using the developed techniques. MR contrast may be used in conventional protocol when it is needed to evaluate the performance of the developed techniques
Time frame: Within one year of scans
Images collected from both investigational MRI pulse sequences and conventional protocol will be reviewed and scored by readers and compared.
Time frame: Within one year of scans
In patient study, the analysis of adverse plaque characteristics will be performed and compared between the conventional protocol and developed protocol.
Time frame: Within one year of scans
Contrast-to-noise ratio will be measured on the images collected with the conventional protocol and developed protocol and compared.
Cedars-Sinai Medical Center
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00597883
Arterial Occlusive Diseases, Brain Diseases
New York, United States
View Trial DetailsNCT00587717
Brain Diseases, Cardiovascular Diseases
View Trial DetailsNCT02126982
Acute Coronary Syndrome, Arrhythmias, Cardiac
Ioannina, Epirus, Greece
View Trial DetailsNCT00619775
Brain Diseases, Cardiovascular Diseases
Mesa, Arizona, United States
View Trial Details